» Articles » PMID: 31414918

The Applications of Metabolomics in the Molecular Diagnostics of Cancer

Overview
Specialty Molecular Biology
Date 2019 Aug 16
PMID 31414918
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

: Metabolomics, the study of metabolites, is a promising research field for cancers. The metabolic pathway in a tumor cell is different from a normal tissue cell. There are two approaches to study the metabolism, targeted and untargeted. The general approach is that metabolomic data are interpreted by bioinformatics tools correlating with metabolomic databases to obtain significant findings. With the use of specific analysis tools, such as nuclear magnetic resonance (NMR) and mass spectrometer (MS) combined with chromatography, metabolic profile or metabolic fingerprint of various biological specimens could be obtained. The applications of metabolomics are used to discover potential cancer biomarkers and monitor the metastatic state, therapeutic and drug response for better patient management. : In this review, the author introduce metabolomics and discuss the use of metabolomics approaches in different cancers, including the study of colorectal cancer, prostate cancer, liver cancer, pancreatic cancer and breast cancer using NMR and MS. : Knowledge on the molecular basis of cancer metabolism and its potential clinical applications has been improving recently. However, there are still many challenges for the technological development and integration of metabolomics with other omics spaces such as genomics. In the near future, it is expected that metabolomics will play an important role in cancer molecular diagnostics.

Citing Articles

Advances in multi-omics studies of microvascular invasion in hepatocellular carcinoma.

Wang L, Xu H, Wang R, Zhang F, Deng D, Zhu X Eur J Med Res. 2025; 30(1):165.

PMID: 40075448 PMC: 11905518. DOI: 10.1186/s40001-025-02421-w.


Interplay between lncRNAs and the PI3K/AKT signaling pathway in the progression of digestive system neoplasms (Review).

Zhang X, Shi L, Xing M, Li C, Ma F, Ma Y Int J Mol Med. 2024; 55(1).

PMID: 39513614 PMC: 11573320. DOI: 10.3892/ijmm.2024.5456.


Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging features.

Yang M, Yu H, Feng H, Duan J, Wang K, Tong B J Transl Med. 2024; 22(1):984.

PMID: 39482707 PMC: 11526513. DOI: 10.1186/s12967-024-05723-5.


Plant Metabolomics: The Future of Anticancer Drug Discovery.

Dabbousy R, Rima M, Roufayel R, Rahal M, Legros C, Sabatier J Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458949 PMC: 11510165. DOI: 10.3390/ph17101307.


Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification.

Hachem S, Yehya A, El Masri J, Mavingire N, Johnson J, Dwead A Biology (Basel). 2024; 13(10).

PMID: 39452071 PMC: 11504278. DOI: 10.3390/biology13100762.